Audit 25206

FY End
2022-12-31
Total Expended
$3.60M
Findings
2
Programs
1
Year: 2022 Accepted: 2023-09-27
Auditor: Bdo USA PC

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
30416 2022-001 - - AB
606858 2022-001 - - AB

Programs

ALN Program Spent Major Findings
93.498 Provider Relief Fund $3.60M Yes 1

Contacts

Name Title Type
QVL2DKG1GJL3 Willard Derr Auditee
5166261000 Adam Cole Auditor
No contacts on file

Notes to SEFA

Title: Note 4 Donated Personal Protective Equipment (Unaudited) Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of NYSARC, Inc. Nassau County Chapter (the Company) under the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Program (the PRF Program) of the federal government for the year ended December 31, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), with the exception of the matter discussed in Note 6 below. Because the Schedule presents only a selected portion of the operations of the Company, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Company. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement, with the exception of the matter discussed in Note 6 below. De Minimis Rate Used: N Rate Explanation: The Company has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. During the year ended December 31, 2022, the Company did not receive any personal protective equipment.
Title: Note 5 Entities Included in the Schedule Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of NYSARC, Inc. Nassau County Chapter (the Company) under the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Program (the PRF Program) of the federal government for the year ended December 31, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), with the exception of the matter discussed in Note 6 below. Because the Schedule presents only a selected portion of the operations of the Company, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Company. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement, with the exception of the matter discussed in Note 6 below. De Minimis Rate Used: N Rate Explanation: The Company has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying Schedule includes the following entities as identified by individual tax identification number (TIN) and entity name: 11-1720254 NYSARC, Inc. Nassau County Chapter
Title: Note6 Provider Relief Fund and American Rescue Plan (ARP)Rural Distribution Accounting Policies: The accompanying schedule of expenditures of federal awards (the Schedule) includes the federal award activity of NYSARC, Inc. Nassau County Chapter (the Company) under the Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Program (the PRF Program) of the federal government for the year ended December 31, 2022. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance), with the exception of the matter discussed in Note 6 below. Because the Schedule presents only a selected portion of the operations of the Company, it is not intended to and does not present the financial position, changes in net assets, or cash flows of the Company. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement, with the exception of the matter discussed in Note 6 below. De Minimis Rate Used: N Rate Explanation: The Company has elected not to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. The total PRF Program expenditures on the Schedule includes $604,017 of lost revenues and $2,991,139 of out-of-period expenditures which are reported in accordance with the terms and conditions included in the Health Resources and Services Administration (HRSA) Post-Payment Notice of Reporting Requirements specific to the PRF Program. Lost revenues and out-of-period expenditures are not permitted concepts under accounting principles generally accepted in the United States of America (U.S. GAAP). Therefore, an adverse opinion due to a departure from U.S. GAAP has been issued on the Schedule.

Finding Details

2022-001- Activities Allowed or Unallowed; Allowable Costs/Cost Principles - Noncompliance Information on Federal Program: U.S Department of Health and Human Service, Award Listing Number 93.498. Criteria: The Health Resources and Services Administration (HRSA) provided recipients of the U.S. Department of Health and Human Services COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Program (PRF Program) with a user guide to assist recipients with the requirements of the allowable reimbursable cost under the PRF Program. The user guide defines an allowable expense under the Provider Relief Fund is a necessary and reasonable expense that is used to prevent, prepare for, and respond to COVID-19. Condition: During our testing of disbursements, we noted that two of the forty expenditures sampled are not an allowable expense and were incorrectly submitted for reimbursement. These expenditures were not considered reasonable and necessary to prevent, prepare for or respond to COVID-19. Questioned Costs: Known questioned costs of $127. Unable to determine unknown questioned costs. Cause: Policies and procedures were not appropriately adhered to in certain instances to ensure that supporting documentation was maintained correctly to evidence that costs were allowable and that an appropriate level of review and approval was completed prior to charging costs to the federal program. Effect: Unallowable expenses were submitted for reimbursement and were claimed as federal expenditures. Context: We tested a sample of forty expenditures and found two exceptions as noted in the condition. We noted the two exceptions totaled $127 of expenditures that are unallowable per the HRSA user guide. This is a condition identified per review of the Company?s compliance with specified requirements using a statistically valid sample. The overall effect on the Company?s Period 4 portal submission would not have changed, as the Company has sufficient unused lost revenues to be reported on the Company?s Period 4 portal submission in lieu of the questioned costs. Recommendation: We recommend that the Company ensure its policies and procedures are followed on a consistent basis. Views of Responsible Officials: The Company agrees with the finding identified. The Company?s response to the finding is described in the accompanying management?s corrective action plan.
2022-001- Activities Allowed or Unallowed; Allowable Costs/Cost Principles - Noncompliance Information on Federal Program: U.S Department of Health and Human Service, Award Listing Number 93.498. Criteria: The Health Resources and Services Administration (HRSA) provided recipients of the U.S. Department of Health and Human Services COVID-19 Provider Relief Fund and American Rescue Plan (ARP) Rural Distribution Program (PRF Program) with a user guide to assist recipients with the requirements of the allowable reimbursable cost under the PRF Program. The user guide defines an allowable expense under the Provider Relief Fund is a necessary and reasonable expense that is used to prevent, prepare for, and respond to COVID-19. Condition: During our testing of disbursements, we noted that two of the forty expenditures sampled are not an allowable expense and were incorrectly submitted for reimbursement. These expenditures were not considered reasonable and necessary to prevent, prepare for or respond to COVID-19. Questioned Costs: Known questioned costs of $127. Unable to determine unknown questioned costs. Cause: Policies and procedures were not appropriately adhered to in certain instances to ensure that supporting documentation was maintained correctly to evidence that costs were allowable and that an appropriate level of review and approval was completed prior to charging costs to the federal program. Effect: Unallowable expenses were submitted for reimbursement and were claimed as federal expenditures. Context: We tested a sample of forty expenditures and found two exceptions as noted in the condition. We noted the two exceptions totaled $127 of expenditures that are unallowable per the HRSA user guide. This is a condition identified per review of the Company?s compliance with specified requirements using a statistically valid sample. The overall effect on the Company?s Period 4 portal submission would not have changed, as the Company has sufficient unused lost revenues to be reported on the Company?s Period 4 portal submission in lieu of the questioned costs. Recommendation: We recommend that the Company ensure its policies and procedures are followed on a consistent basis. Views of Responsible Officials: The Company agrees with the finding identified. The Company?s response to the finding is described in the accompanying management?s corrective action plan.